PCG
GILD icon

Prosperity Consulting Group’s Gilead Sciences GILD Stock Holding History

Prosperity Consulting Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.85M Sell
27,641
-1,525
-5% -$214K 0.17% 96
2025
Q4 		$3.58M Buy
29,166
+321
+1% +$39K 0.16% 102
2025
Q3 		$3.2M Sell
28,845
-559
-2% -$63.5K 0.16% 113
2025
Q2 		$3.26M Buy
29,404
+4,107
+16% +$437K 0.24% 98
2025
Q1 		$2.83M Sell
25,297
-1,500
-6% -$155K 0.22% 105
2024
Q4 		$2.48M Sell
26,797
-1,767
-6% -$159K 0.19% 124
2024
Q3 		$2.39M Sell
28,564
-7,806
-21% -$596K 0.19% 127
2024
Q2 		$2.5M Sell
36,370
-16,615
-31% -$1.11M 0.34% 76
2024
Q1 		$3.88M Buy
52,985
+48,832
+1,176% +$3.76M 0.49% 58
2023
Q4 		$336K Buy
+4,153
New +$323K 0.11% 151

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prosperity Consulting Group's GILD Position: Q1 2026 in Review

Prosperity Consulting Group reduced its Gilead Sciences (GILD) stake by 5.2% in Q1 2026, selling an estimated $214K and leaving 27,641 shares worth $3.85M. The position accounts for 0.17% of the portfolio, ranked #96.

Prosperity Consulting Group first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.88M in Q1 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Prosperity Consulting Group held 27,641 shares of Gilead Sciences worth $3.85M as of Q1 2026.
  • Prosperity Consulting Group sold 1,525 Gilead Sciences shares in Q1 2026, an estimated $214K.
  • Gilead Sciences made up 0.17% of Prosperity Consulting Group's portfolio in Q1 2026, its #96 holding.
  • Prosperity Consulting Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Prosperity Consulting Group's Gilead Sciences position peaked at $3.88M in Q1 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Prosperity Consulting Group's 13F filing for Q1 2026, filed 5 May 2026.